-
摘要: 神经内分泌肿瘤(neuroendocrine neoplasia, NEN)较罕见, 部分NEN可分泌过量激素, 引起患者血压升高, 是继发性高血压的重要病因。导致高血压的NEN包括嗜铬细胞瘤/副神经节瘤、垂体生长激素瘤、垂体促肾上腺皮质激素瘤、甲状旁腺腺瘤/腺癌以及异位分泌激素的NEN。此类患者除高血压症状外, 常伴有其他典型临床特征, 但部分患者临床症状并不明显, 需在早期加以识别。近年来, 随着新的核素显像技术等应用于临床, 极大提高了此类疾病的检出率, 使更多患者得到及时诊治。Abstract: Neuroendocrine neoplasias (NENs) are rare. Some NENs secrete hormone, thus causing hypertension of the patients. NENs are important causes of secondary hypertension, which include pheochromocytoma and paraganglioma, growth hormone-secreting pituitary adenoma, adrenocorticotropic hormone-secreting pituitary adenoma, parathyroid adenoma and carcinoma, and ectopic hormone-secreting NENs. Apart from hypertension, most NEN patients had other typical clinical features that need to be identified at early stage. In recent years, with the application of new technologies of nuclide imaging, the detection rate of these diseases has been greatly improved, and more patients can be diagnosed and treated early.
-
Key words:
- neuroendocrine neoplasia /
- hypertension /
- diagnosis
利益冲突 无 -
[1] 王连唐, 程嘉骧, 黄世章.内分泌病理学[M].江西:江西科学技术出版社, 2006:253-296. [2] 中华医学会内分泌学分会肾上腺学组.嗜铬细胞瘤和副神经节瘤诊断治疗的专家共识[J].中华内分泌代谢杂志, 2016, 32:181-187. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhnfmdx201603002 [3] Zuber SM, Kantorovich V, Pacak K. Hypertension in pheochromocytoma:characteristics and treatment[J]. Endocrinol Metab Clin North Am, 2011, 40:295-311. doi: 10.1016/j.ecl.2011.02.002 [4] 樊华, 李汉忠, 纪志刚, 等.嗜铬细胞瘤/副神经节瘤术中血压骤升的临床特征分析(附单中心219例报告)[J].中华泌尿外科杂志, 2019, 40:267-271. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhmnwk201904007 [5] Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma:an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2014, 99:1915-1942. doi: 10.1210/jc.2014-1498 [6] 景红丽.生长抑素受体显像在嗜铬细胞瘤、副神经节瘤和肿瘤性骨软化症的临床应用研究[D].北京: 中国医学科学院北京协和医院, 2016. [7] Janssen I, Blanchet EM, Adams K, et al. Superiority of[68Ga]-DOTATATE PET/CT to other functional imaging modalities in the localization of SDHB-associated metastatic pheochromocytoma and paraganglioma[J]. Clin Cancer Res, 2015, 21:3888-3895. doi: 10.1158/1078-0432.CCR-14-2751 [8] 邓建华, 李汉忠.嗜铬细胞瘤/副神经节瘤基因突变相关遗传综合征[J].协和医学杂志, 2015, 6:161-165. http://d.wanfangdata.com.cn/periodical/xhyx201503001 [9] Neumann HPH, Young WF, Eng C. Pheochromocytoma and paraganglioma[J]. N Engl J Med, 2019, 381:552-565. doi: 10.1056/NEJMra1806651 [10] Colao A, Grasso LFS, Giustina A, et al. Acromegaly[J]. Nat Rev Dis Primers, 2019, 5:20. doi: 10.1038/s41572-019-0071-6 [11] Puglisi S, Terzolo M. Hypertension and acromegaly[J]. Endocrinol Metab Clin North Am, 2019, 48:779-793. doi: 10.1016/j.ecl.2019.08.008 [12] Vilar L, Vilar CF, Lyra R, et al. Acromegaly:clinical features at diagnosis[J]. Pituitary, 2017, 20:22-32. doi: 10.1007/s11102-016-0772-8 [13] Katznelson L, Laws ER, Melmed S, et al. Acromegaly:an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2014, 99:3933-3951. doi: 10.1210/jc.2014-2700 [14] Zahr R, Fleseriu M. Updates in diagnosis and treatment of acromegaly[J]. Eur Endocrinol, 2018, 14:57-61. doi: 10.17925/EE.2018.14.2.57 [15] Lloyd RV, Osamura RY, Kloppel G, et al. WHO classification of tumours of endocrine organs[M]. 4th ed. Lyon:International Agency for Research on Cancer, 2017:12-23. [16] Trouillas J, Jaffrain-Rea ML, Vasiljevic A, et al. How to classify the pituitary neuroendocrine tumors (PitNET)s in 2020[J]. Cancers (Basel), 2020, 12. pii:E514.doi: 10.3390/cancers12020514. [17] Stelmachowska-Banas M, Glogowski M, Vasiljevic A, et al. Ectopic acromegaly due to growth hormone-releasing hormone secretion from bronchial carcinoid causing somatotroph hyperplasia and partial pituitary insufficiency[J]. Pol Arch Intern Med, 2019, 129:208-210. [18] 中华医学会内分泌学分会.库欣综合征专家共识(2001年)[J].中华内分泌代谢杂志, 2011, 28:96-102. [19] Barbot M, Ceccato F, Scaroni C. The pathophysiology and treatment of hypertension in patients with Cushing's syndrome[J]. Front Endocrinol (Lausanne), 2019, 10:321. doi: 10.3389/fendo.2019.00321 [20] Araujo Castro M, Marazuela Azpiroz M. Two types of ectopic Cushing syndrome or a continuum? Review[J]. Pituitary, 2018, 21:535-544. doi: 10.1007/s11102-018-0894-2 [21] Isidori AM, Sbardella E, Zatelli MC, et al. Conventional and nuclear medicine imaging in ectopic Cushing's syndrome:A systematic review[J]. J Clin Endocrinol Metab, 2015, 100:3231-3244. doi: 10.1210/JC.2015-1589 [22] Kalla A, Krishnamoorthy P, Gopalakrishnan A, et al. Primary hyperparathyroidism predicts hypertension:Results from the National Inpatient Sample[J]. Int J Cardiol, 2017, 227:335-337. doi: 10.1016/j.ijcard.2016.11.080 [23] Graff-Baker AN, Bridges LT, Chen Q, et al. Parathyroidectomy for patients with primary hyperparathyroidism and associations with hypertension[J]. JAMA Surg, 2019, 155:32-39. https://www.ncbi.nlm.nih.gov/pubmed/31596437 [24] Fisher SB, Perrier ND. Primary hyperparathyroidism and hypertension[J]. Gland Surg, 2020, 9:142-149. doi: 10.21037/gs.2019.10.21
点击查看大图
计量
- 文章访问数: 440
- HTML全文浏览量: 66
- PDF下载量: 70
- 被引次数: 0